DeepMind releases AlphaGenome 2 to predict DNA effects per cell type
What is AlphaGenome 2: Deciphering how cells read DNA to better understand disease?
AlphaGenome 2 is a deep-learning model that forecasts how a DNA sequence or a single-letter mutation will turn genes on or off in any of hundreds of human cell types. It lets scientists see which cells a variant is likely to affect, helping link genetics to disease.
Who it is for
Geneticists, drug developers and clinicians can use it to focus on variants that matter in the right cell context.
How to try it
Open the AlphaGenome 2 demo on DeepMind’s website
The story so far
Early Signal first spotted AlphaGenome 2: Deciphering how cells read DNA to better understand disease on November 11, 2026.
Questions about AlphaGenome 2: Deciphering how cells read DNA to better understand disease
- How do I try AlphaGenome 2: Deciphering how cells read DNA to better understand disease?
- Open the AlphaGenome 2 demo on DeepMind’s website